Internal Medicine · Philadelphia, PA
NPI
1265470306
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
9892 Bustleton Ave, Suite 103
Philadelphia, PA, 19115
Phone (215) 897-9090
Groups this clinician bills Medicare through
Medicare paid, 2024
$248K
3,798 services
Medicare patients, 2024
672
Average age 78
Drug cost, 2024
$4.1M
59,486 prescriptions
Company payments, 2025
$1,424
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sergei V Chekov was code 99213 (office e&m - established), 1,522 times for 467 patients. In total Sergei V Chekov billed 3,798 services in 21 codes, and Medicare paid $248K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-06-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,522 | 467 | $61.98 | $94K |
| 99348 Home E&M - New and Established | Office | 1,367 | 175 | $52.86 | $72K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 390 | 390 | $126.32 | $49K |
| 90661 Vaccine Product | Office | 119 | 119 | $36.11 | $4,297 |
| G0008 Administration of influenza virus vaccine | Office | 119 | 119 | $33.29 | $3,962 |
| 96372 Injection Administration | Office | 70 | 21 | $10.75 | $752 |
| 99349 Home E&M - New and Established | Office | 49 | 42 | $92.13 | $4,514 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 28 | 26 | $218.19 | $6,109 |
| G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 28 | 28 | $162.00 | $4,536 |
| 99214 Office E&M - Established | Office | 21 | 18 | $88.91 | $1,867 |
| 93000 Electrocardiogram | Office | 20 | 20 | $10.12 | $202 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 19 | 17 | $41.94 | $797 |
| 99204 Office E&M - New | Office | 11 | 11 | $119.32 | $1,313 |
By year: 2022 $241K for 3,740 services; 2023 $243K for 4,064 services; 2024 $248K for 3,798 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sergei V Chekov prescribed most often to Medicare patients was Amlodipine Besylate, with 2,193 prescriptions and refills. In total Sergei V Chekov wrote 59,486 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 2,193 | 2,517 | 259 | $8,532 |
| Atorvastatin Calcium Generic | 1,768 | 2,014 | 206 | $10K |
| Pantoprazole Sodium Generic | 1,695 | 1,854 | 202 | $13K |
| Rosuvastatin Calcium Generic | 1,689 | 2,046 | 230 | $13K |
| Losartan Potassium Generic | 1,651 | 1,859 | 209 | $9,053 |
| Furosemide Generic | 1,446 | 1,530 | 176 | $2,749 |
| Levothyroxine Sodium Generic | 1,362 | 1,554 | 145 | $7,847 |
| Omeprazole Generic | 1,298 | 1,473 | 150 | $8,193 |
| Diclofenac Sodium Generic | 1,230 | 1,260 | 197 | $113K |
| Metoprolol Tartrate Generic | 1,128 | 1,212 | 118 | $3,728 |
| Gabapentin Generic | 1,073 | 1,135 | 138 | $6,063 |
| Metoprolol Succinate Generic | 1,061 | 1,203 | 129 | $8,328 |
| Metformin Hcl Generic | 935 | 1,083 | 107 | $4,864 |
| Alprazolam Generic | 932 | 942 | 126 | $2,511 |
| Levocetirizine Dihydrochloride Generic | 917 | 983 | 105 | $3,394 |
Brand drugs: 7,374 claims; generic drugs: 51,644 claims; opioid claims: 402.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sergei V Chekov $1,424 ($1,424 in general payments such as food, travel and fees) from 24 companies. The largest payer was Abbvie Inc. with $273.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 14 | $273 |
| Aimmune Therapeutics, Inc. | 18 | $239 |
| Novo Nordisk Inc NVO | 4 | $99.84 |
| Sumitomo Pharma America, Inc. 4506.T | 4 | $88.73 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $78.08 |
| Pfizer Inc. PFE | 4 | $70.43 |
| Janssen Pharmaceuticals, Inc JNJ | 2 | $67.21 |
| Ardelyx, Inc. ARDX | 3 | $67 |
| GlaxoSmithKline, LLC. GSK | 2 | $50.27 |
| Kowa Pharmaceuticals America, Inc. | 3 | $48.11 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.